TY - JOUR
T1 - Analytical considerations for quantitative determination of serotonin and its metabolically related products in biological matrices
AU - Mailman, Richard
AU - Kilts, C. D.
PY - 1985
Y1 - 1985
N2 - We discuss the use of 'high-performance' liquid chromatography with electrochemical detection for the quantification of serotonin (5-hydroxytryptamine) and metabolically related products (i.e., 5-hydroxyindoleacetic acid and 5-hydroxytryptophan) in biological matrices. Two methods are described: one for routine quantification of nanogram amounts or more; the other a two-column purification-separation ('trace enrichment') technique for determining subnanogram amounts of these compounds. Various factors affecting the liquid-chromatographic separation and quantification of 5-hydroxyindoles are detailed, including selection of appropriate internal standard, sample purification, and effects of changes in mobile phase composition, e.g., ion-pair reagent, organic modifier content, and pH. We describe in detail the trace-enrichment method for determinations in the range of 25 pg to 25 ng, and discuss the general factors to consider when developing or modifying an assay for specific applications.
AB - We discuss the use of 'high-performance' liquid chromatography with electrochemical detection for the quantification of serotonin (5-hydroxytryptamine) and metabolically related products (i.e., 5-hydroxyindoleacetic acid and 5-hydroxytryptophan) in biological matrices. Two methods are described: one for routine quantification of nanogram amounts or more; the other a two-column purification-separation ('trace enrichment') technique for determining subnanogram amounts of these compounds. Various factors affecting the liquid-chromatographic separation and quantification of 5-hydroxyindoles are detailed, including selection of appropriate internal standard, sample purification, and effects of changes in mobile phase composition, e.g., ion-pair reagent, organic modifier content, and pH. We describe in detail the trace-enrichment method for determinations in the range of 25 pg to 25 ng, and discuss the general factors to consider when developing or modifying an assay for specific applications.
UR - http://www.scopus.com/inward/record.url?scp=0022234848&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022234848&partnerID=8YFLogxK
U2 - 10.1093/clinchem/31.11.1849
DO - 10.1093/clinchem/31.11.1849
M3 - Article
C2 - 2414038
AN - SCOPUS:0022234848
SN - 0009-9147
VL - 31
SP - 1849
EP - 1854
JO - Clinical chemistry
JF - Clinical chemistry
IS - 11
ER -